HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Youdim, S. Search for Related Content PubMed Articles by Youdim, S.

Resistance to Tumor Growth Mediated by Listeria Monocytogenes. Destruction of Experimental Malignant Melanoma by Lm-Activated Peritoneal and Lymphoid Cells¹

From the Department of Pathology, University of California, San Diego, School of Medicine, La Jolla, California 92037

Abstract

A murine experimental model of nonspecific tumor destruction mediated by cells activated by Listeria monocytogenes (LM) is described. B16 melanoma growth is prevented or suppressed in the syngeneic host when tumor cells are inoculated in contact with viable LM. In vitro, cultured B16 cells are destroyed by LM immune peritoneal or splenic cells in the presence of the bacterial antigen(s). Activation of LM immune cells in vitro is immunologically specific. Replacement of LM by sheep red blood cells or bovine serum albumin in the in vitro cultures aborts the cytotoxic effect. Further, no tumor cell killing is obtained when thioglycollate-induced or normal peritoneal cells are substituted for LM immune cells in the in vitro cultures. Normal spleen cells in the presence of LM are weakly cytotoxic for B16 cells. Normal peritoneal cells plus LM or LM alone are not. Elimination of thymus derived "T" cells by anti- C3H or rabbit anti-mouse brain serum (RAMB) abrogated the cytotoxic effect. Therefore, LM-induced tumor destruction probably occurs through nonspecific mechanism(s) consequent to activation of host "T" cells by specific immune reactivity to LM antigen(s).

Footnotes

¹ This investigation was supported by the United States Public Health Service Grants CA15240, CA17299 and HL14169.

This article has been cited by other articles:

				B. D. X. Lascelles, W. S. Dernell, M. T. Correa, M. Lafferty, C. M. Devitt, C. A. Kuntz, R. C. Straw, and S. J. Withrow Improved Survival Associated With Postoperative Wound Infection in Dogs Treated With Limb-Salvage Surgery for Osteosarcoma Ann. Surg. Oncol., December 1, 2005; 12(12): 1073 - 1083. [Abstract] [Full Text] [PDF]